1. Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme. Issue 3 (21st September 2018) Authors: Palace, Jacqueline; Duddy, Martin; Lawton, Michael; Bregenzer, Thomas; Zhu, Feng; Boggild, Mike; Piske, Benjamin; Robertson, Neil P; Oger, Joel; Tremlett, Helen; Tilling, Kate; Ben-Shlomo, Yoav; Lilford, Richard; Dobson, Charles Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 3(2019) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator. Issue 5 (May 2015) Authors: Palace, Jacqueline; Duddy, Martin; Bregenzer, Thomas; Lawton, Michael; Zhu, Feng; Boggild, Mike; Piske, Benjamin; Robertson, Neil P; Oger, Joel; Tremlett, Helen; Tilling, Kate; Ben-Shlomo, Yoav; Dobson, Charles Journal: Lancet neurology Issue: Volume 14:Issue 5(2015:May) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THE UK RISK SHARING SCHEME: FINAL 10 YEAR ANALYSIS. Issue 12 (15th November 2016) Authors: Palace, Jacqueline; Duddy, Martin; Bregenzer, Thomas; Piske, Benjamin; Lawton, Michael; Joel, Feng Zhu; Tremlett, Oger Helen; Boggild, Mike; Robertson, Neil; Lilford, Richard; Tilling, Kate; Ben-Shlomo, Yoav; Potter, Claire; Dobson, Charles Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 87:Issue 12(2016) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗